ABSTRACT
The liver is the third most common site of metastases from carcinoma of the breast, after the bone and lung. Two-thirds of women with metastatic breast cancer eventually have it spread to the liver. Complete evaluation of the extent of metastatic disease, both within and outside the liver, is important before considering treatment options. Although systemic treatments are the mainstay of therapy, there has been an increasing interest in the role of local therapy of liver metastases in specific circumstances for women with metastatic breast cancer.
